proellex News
Most Popular proellex Story
FDA expresses doubt about Repros' Proellex
The FDA has informed Repros Therapeutics (RPRX) that it will need to resolve a number of outstanding issues with its drug Proellex before the clinical hold on the drug can be lifted. In August, Read more...
Latest Headlines
- April 30, 2010
- September 29, 2009
- August 3, 2009
- July 1, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
